Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Oxford Simulation, Teaching and Research Centre has been busier than ever during the coronavirus pandemic

Intubation team of two men and a woman in full personal protective equipment

OxSTaR (Oxford Simulation, Teaching and Research) is the University of Oxford’s state-of-the-art medical simulation, teaching and research facility. This unit, led by Dr Helen Higham, is part of the Nuffield Division of Anaesthetics in the Nuffield Department of Clinical Neurosciences. 

For 12 years, OxSTaR has been running simulated scenarios — complete with highly realistic functioning models of patients known as manikins — to understand and improve how healthcare professionals work together and interact with their environment and equipment. They have used the insights gained to provide training across Oxford University Hospitals (OUH). Recent weeks have seen them rise to the unique challenge of supporting front-line clinical staff during a pandemic.

Read more on the University of Oxford Medium channel

 

Similar stories

Professor Irene Tracey nominated as Vice-Chancellor of the University of Oxford

Professor of Anaesthetic Neuroscience Irene Tracey, former head of the Nuffield Department of Clinical Neurosciences, has been nominated as the next Vice-Chancellor of the University of Oxford.

Brain regions related to smell show decline following mild COVID-19

Researchers from the University of Oxford have used data from UK Biobank participants to look at changes to the brain on average 4.5 months after mild SARS-CoV-2 infection.

Attention and memory deficits persist for months after recovery from mild COVID

Researchers from Oxford’s Nuffield Department of Clinical Neurosciences and Department of Experimental Psychology have shown that people who have had COVID but don’t complain of long COVID symptoms in daily life nevertheless can show degraded attention and memory for up to six to nine months.

Research finds drug may benefit some patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.

Evaluating risk to people with epilepsy during the COVID-19 pandemic - study wins international prize

In May 2020 our researchers initiated a global project to investigate how COVID-19 has affected people with epilepsy, their carers and health care workers.

COVID-19 infection has greater risk than vaccines of causing very rare neurological events

Research reveals risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.